FDA Video - Early Communication on Adverse Events from Botox and Myobloc
-
Early Communication on Adverse Events from Botox and Myobloc
FDA has issued an early communication about serious adverse events, including respiratory failure and death, from Botox and Botox Cosmetic (Botulinum toxin Type A), and Myobloc (Botulinum toxin Type B). These events were related to how the product
Run Time: 1:51
Share this Video
Search Videos
Editor's Choice
Current Issues in the Saf
Run Time: 30:43
Bad Reactions to Cosmetic
Run Time: 01:23
FDA Basics: Dr. Linda Kat
Run Time: 02:43
Recently Added
Bad Reactions to Cosmetic
Run Time: 01:34
Current Issues in the Saf
Run Time: 30:43
FDA Basics: Dr. Linda Kat
Run Time: 05:28
Early Communication on Ad
Run Time: 01:51
-
